XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Shareholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Capital Surplus
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net of Tax
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2020   71,753,705        
Balance at beginning of period (in shares) at Dec. 31, 2020           2,212,224
Balance at beginning of period at Dec. 31, 2020 $ 2,647,088 $ 71,754 $ 1,913,285 $ 671,510 $ 33,505 $ (42,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   99,308        
Issuance of restricted shares 599 $ 99 500      
Forfeitures of restricted shares (in shares)   (2,695)        
Forfeitures of restricted shares (53) $ (3) (50)      
Proceeds from exercise of stock options (in shares)   165,608        
Proceeds from exercise of stock options 4,499 $ 166 4,333      
Share-based compensation 4,896   4,896      
Purchase of treasury shares (in shares)           168,267
Purchase of treasury shares (8,108)         $ (8,108)
Net income 294,969     294,969    
Dividends on common shares (31,500)     (31,500)    
Other comprehensive loss during the period (11,620)       (11,620)  
Balance at end of period (in shares) at Sep. 30, 2021   72,015,926        
Balance at end of period (in shares) at Sep. 30, 2021           2,380,491
Balance at end of period at Sep. 30, 2021 2,900,770 $ 72,016 1,922,964 934,979 21,885 $ (51,074)
Balance at beginning of period (in shares) at Jun. 30, 2021   72,007,871        
Balance at beginning of period (in shares) at Jun. 30, 2021           2,240,662
Balance at beginning of period at Jun. 30, 2021 2,837,004 $ 72,008 1,920,566 863,828 25,024 $ (44,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Forfeitures of restricted shares (in shares)   (1,945)        
Forfeitures of restricted shares (33) $ (2) (31)      
Proceeds from exercise of stock options (in shares)   10,000        
Proceeds from exercise of stock options 288 $ 10 278      
Share-based compensation 2,151   2,151      
Purchase of treasury shares (in shares)           139,829
Purchase of treasury shares (6,652)         $ (6,652)
Net income 81,680     81,680    
Dividends on common shares (10,529)     (10,529)    
Other comprehensive loss during the period (3,139)       (3,139)  
Balance at end of period (in shares) at Sep. 30, 2021   72,015,926        
Balance at end of period (in shares) at Sep. 30, 2021           2,380,491
Balance at end of period at Sep. 30, 2021 $ 2,900,770 $ 72,016 1,922,964 934,979 21,885 $ (51,074)
Balance at beginning of period (in shares) at Dec. 31, 2021   72,017,126        
Balance at beginning of period (in shares) at Dec. 31, 2021 2,407,898         2,407,898
Balance at beginning of period at Dec. 31, 2021 $ 2,966,451 $ 72,017 1,924,813 1,006,436 15,590 $ (52,405)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   164,346        
Issuance of restricted shares 1,341 $ 164 1,177      
Forfeitures of restricted shares (in shares)   (13,889)        
Forfeitures of restricted shares (133) $ (14) (119)      
Proceeds from exercise of stock options (in shares)   79,803        
Proceeds from exercise of stock options 2,324 $ 80 2,244      
Share-based compensation 4,791   4,791      
Purchase of treasury shares (in shares)           486,779
Purchase of treasury shares (22,421)         $ (22,421)
Net income 264,319     264,319    
Dividends on common shares (31,278)     (31,278)    
Other comprehensive loss during the period $ (66,324)       (66,324)  
Balance at end of period (in shares) at Sep. 30, 2022   72,247,386        
Balance at end of period (in shares) at Sep. 30, 2022 2,894,677         2,894,677
Balance at end of period at Sep. 30, 2022 $ 3,119,070 $ 72,247 1,932,906 1,239,477 (50,734) $ (74,826)
Balance at beginning of period (in shares) at Jun. 30, 2022   72,251,856        
Balance at beginning of period (in shares) at Jun. 30, 2022           2,891,395
Balance at beginning of period at Jun. 30, 2022 3,073,376 $ 72,251 1,931,088 1,157,359 (12,635) $ (74,687)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Forfeitures of restricted shares (in shares)   (4,470)        
Forfeitures of restricted shares (42) $ (4) (38)      
Share-based compensation 1,856   1,856      
Purchase of treasury shares (in shares)           3,282
Purchase of treasury shares (139)         $ (139)
Net income 92,555     92,555    
Dividends on common shares (10,437)     (10,437)    
Other comprehensive loss during the period $ (38,099)       (38,099)  
Balance at end of period (in shares) at Sep. 30, 2022   72,247,386        
Balance at end of period (in shares) at Sep. 30, 2022 2,894,677         2,894,677
Balance at end of period at Sep. 30, 2022 $ 3,119,070 $ 72,247 $ 1,932,906 $ 1,239,477 $ (50,734) $ (74,826)